Clinical

Researchers at St. Jude are investigating how to approach difficult conversations about prognosis with patients and their families.

St. Jude scientists contributed to a phase 3 clinical trial showing that blinatumomab added to chemotherapy is effective against leukemia in adults.

Childhood cancer survivors are at an increased risk of major adverse cardiovascular events, making safeguarding heart health a priority.

Factors like family anxiety and neighborhood adversity contribute to symptom burden in childhood cancer survivors and the need for comprehensive care.

Phase II clinical trial results show promise in reducing graft-versus-host disease

Closing the time gap between pediatric and adult care could have significant benefits for patients.

St. Jude scientists have found for the first time that myocardial fibrosis caused by sickle cell disease can actually be improved by bone marrow transplantation.

Discover the neuronal interactions at the center of posterior fossa syndrome

St. Jude and UTHSC are training nurses worldwide how to better care for people with sickle cell disease.

Learn how long-lasting drugs offer hope for adolescent with HIV.